Company Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Business Summary
Number of employees: 141
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Allison Nance
LAW | General Counsel | - | 16-04-30 |
Ted Harding
HRO | Human Resources Officer | - | - |
General Counsel | - | 19-09-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,635,468 | 41,318,605 ( 78.50 %) | 0 | 78.50 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |